Calming and Sleeping in Australia

  • April 2014
  • -
  • Euromonitor International
  • -
  • 25 pages

There has been an increase in demand for sleeping and calming products in 2013 with 5% current value growth to reach A$15 million. Growth was largely driven by demographic changes. Insomnia is predominately an issue for consumers aged 50-65 years, especially women reaching menopause. With the number of Australians aged 50-65 years increasing each year, this is fuelling growth for calming and sleeping products.

Euromonitor International's Calming and Sleeping in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to 2018 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Calming and Sleeping in Australia
CALMING AND SLEEPING IN AUSTRALIA

April 2014

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2008-2013
Table 2 Sales of Calming and Sleeping: % Value Growth 2008-2013
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2009-2013
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2010-2013
Table 5 Forecast Sales of Calming and Sleeping: Value 2013-2018
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2013-2018
Blackmores Ltd in Consumer Health (australia)
Strategic Direction
Key Facts
Summary 1 Blackmores Ltd : Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Blackmores Ltd: Competitive Position 2013
Executive Summary
A Healthy Category in 2013
A Warm Winter Cools Sales
Sanofi-aventis Maintains Its Leading Position
Distribution Continues To Evolve
Growth Will Slow Over the Forecast Period
Key Trends and Developments
Tga Bans Common Ingredients in Paediatric Health Products
Media, Myth and Magic - the Tale of Dietary Supplements
Parapharmacy
Ageing in Australia: the Active and the Obese
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2008-2013
Table 8 Life Expectancy at Birth 2008-2013
Market Data
Table 9 Sales of Consumer Health by Category: Value 2008-2013
Table 10 Sales of Consumer Health by Category: % Value Growth 2008-2013
Table 11 NBO Company Shares of Consumer Health: % Value 2009-2013
Table 12 LBN Brand Shares of Consumer Health: % Value 2010-2013
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2008-2013
Table 14 Distribution of Consumer Health by Format: % Value 2008-2013
Table 15 Distribution of Consumer Health by Format and Category: % Value 2013
Table 16 Forecast Sales of Consumer Health by Category: Value 2013-2018
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2013-2018
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 3 OTC: Switches 2011-2013
Sources
Summary 4 Research Sources












View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • February 2015
  • by Global Data

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, ...

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • January 2015
  • by Global Data

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. ...

European Markets for Soft Tissue Reinforcement and Regeneration

European Markets for Soft Tissue Reinforcement and Regeneration

  • $ 10 995
  • Industry report
  • April 2015
  • by iData Research, Inc.

The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.